Owkin and Evotec partner to accelerate therapeutics in oncology and I&I by Jen Brogan | Jan 5, 2024 | News | 0 The companies will aim to select targets, discover and develop new therapeutics Read More
Green light for cancer drugs developed by AI specialist Owkin by John Pinching | Sep 2, 2022 | News | 0 AI company has its breast cancer and colorectal therapies approved for use in Europe Read More